07:48 AM EST, 02/03/2025 (MT Newswires) -- Pfizer ( PFE ) has resolved the legal challenge filed by advocacy group Do No Harm to the company's Breakthrough fellowship program, with a New York district court dismissing the case Friday.

According to the court document, Pfizer ( PFE ) changed the criteria for the program in February 2023 and has announced that it will no longer accept new applications after the program's fifth and final cohort of fellows.

Do No Harm filed the lawsuit in September 2022, claiming that the program was "racially discriminatory."

Pfizer ( PFE ) did not immediately respond to MT Newswires' request for comment.